SPL.AX · STARPHARMA HOLDINGS LIMITED
Australia · RS rating 95 · As of 2026-10-14
| Price | 0.80 AUD |
|---|---|
| 1-day change | -3.6% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 87 / 80 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 55 / 32 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +8.1% |
| Market cap (USD) | $282.1M |